METTL3 and cancer: Moreover, the regulatory effect of METTL3 is prevalent in other types of cancers, including glioma [45,46], gastric cancer [47], hepatocellular carcinoma (HCC) [48], breast cancer (BRCA) [49], and acute myeloid leukemia (AML) [50].